87 related articles for article (PubMed ID: 2970607)
1. Catapres-TTS: a two year posttrial followup.
Kellaway GS; Lubbe WF
N Z Med J; 1988 Jun; 101(847 Pt 1):380. PubMed ID: 2970607
[No Abstract] [Full Text] [Related]
2. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
Hollifield J
Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
[No Abstract] [Full Text] [Related]
3. Skin reactions to long-term transdermal clonidine.
Dick JB; Northridge DB; Lawson AA
Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
[No Abstract] [Full Text] [Related]
4. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
Lewis GR
N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
[TBL] [Abstract][Full Text] [Related]
5. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
Chen SW; Vidt DG
Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
[TBL] [Abstract][Full Text] [Related]
6. [Transdermal clonidine: a new therapeutic approach in essential hypertension?].
Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W
Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058
[No Abstract] [Full Text] [Related]
7. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
[TBL] [Abstract][Full Text] [Related]
8. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
Breidthardt J; Schumacher H; Mehlburger L
Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
[TBL] [Abstract][Full Text] [Related]
9. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
Kellaway GS; Lubbe WF
N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertension by a new transdermal form of clonidine.
Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
[TBL] [Abstract][Full Text] [Related]
12. "Catapres in the management of hypertension".
Singh N; Menon V
Med J Malaysia; 1975 Mar; 30(3):209-13. PubMed ID: 1160681
[No Abstract] [Full Text] [Related]
13. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension.
Wallin JD; Krane NK; Bergman S; Morgan M
J Clin Hypertens; 1985 Dec; 1(4):315-21. PubMed ID: 3836300
[TBL] [Abstract][Full Text] [Related]
14. Clonidine (Catapres) for hypertension.
Med Lett Drugs Ther; 1975 May; 17(11):45-6. PubMed ID: 1128440
[No Abstract] [Full Text] [Related]
15. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Frishman WH; Sherman D; Feinfeld DA
Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo functionality of Catapres-TTS.
Enscore DJ; Osborne JL; Shaw JE
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
[TBL] [Abstract][Full Text] [Related]
17. Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
[TBL] [Abstract][Full Text] [Related]
18. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
Ambrosioni E
Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
[TBL] [Abstract][Full Text] [Related]
19. Skin reactions to clonidine: not just a local problem. Case report.
Crivellaro MA; Bonadonna P; Dama A; Senna G; Passalacqua G
Allergol Immunopathol (Madr); 1999; 27(6):318-9. PubMed ID: 10611557
[No Abstract] [Full Text] [Related]
20. Catapres Perlongets in the management of hypertension.
Middleton RS
Practitioner; 1981 Dec; 225(1362):1845-9. PubMed ID: 7335619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
